1 / 90

Practical Hematology Diagnosing Coagulopathy

Practical Hematology Diagnosing Coagulopathy. Wendy Blount, DVM. Practical Hematology. Determining the cause of anemia Treating regenerative anemias Blood loss Hemolysis Treating non-regenerative anemias Blood & plasma transfusions in general practice

les
Download Presentation

Practical Hematology Diagnosing Coagulopathy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Practical HematologyDiagnosing Coagulopathy Wendy Blount, DVM

  2. Practical Hematology • Determining the cause of anemia • Treating regenerative anemias • Blood loss • Hemolysis • Treating non-regenerative anemias • Blood & plasma transfusions in general practice • Determining the causing of coagulopathies • Treating coagulopathies in general practice • Finding the source of leukocytosis • Bone marrow sampling

  3. Hemostasis Primary hemostasis • Platelets plug up damaged blood vessels • Von Willebrand Factor (vWF) • Vasoconstriction Secondary hemostasis • Platelet plug organized by fibrin • Fibrin generated by coagulation cascade (factors) Fibrinolysis

  4. Coagulopathies Poor Clotting • Not enough hemostasis • Problem with primary and/or secondary hemostasis so that clots do not form and stabilize normally Thromboembolic Disease • Too much hemostasis • Natural anticoagulants are missing • Or Fibrinolytics are missing

  5. Signs of Bleeding Primary hemostasis – small vessel hemorrhage • Immediate bleeding • Petechiae (except vWDz) - <3 mm • Ecchymoses • Bleeding from surfaces • Nose, mouth • Ocular - hyphema • GI – hematemesis, melena, hematochezia, hematuria • repro • Prolonged bleeding after injury or surgery

  6. Signs of Bleeding • Secondary hemostasis • Delayed bleeding after injury or surgery • Bleeding into cavities • Joints, pleural space, abdomen • CNS • Muscular hematomas • Hemoptysis – can present as melena • Blood coughed up, swallowed and digested • Both primary and secondary • Epistaxis • Ecchymoses • If severe 1o and 2o bleeding types blend

  7. Assessment of Coagulation • Is bleeding appropriate to injury? • Control arterial bleeding with ligation • If not, assess coag status ASAP • Platelet count • PT, PTT/ACT • BMBT • FDPs, D-dimers • Factor assays

  8. Coagulation Tests Primary hemostasis • Platelet estimate • Count platelets in 10 HPF (oil) • Divide by 10 to get average • Multiply by 15-20,000 • 8-15 platelets/HPF is adequate • Automated platelet count • Look at the feathered edge for platelet clumping (cats!!) • If clumping, get a new sample • Use citrate (blue top) and count immediately

  9. Coagulation Tests Primary hemostasis • MPV – Mean Platelet Volume • Increased in dogs when immature platelets in circulation • Indicates increased platelet pdxn • DIC, vasculitis, chronic hemorrhage • Decreased with IMT - 50% • Large, bizarre platelets • Otter hound thrombocytopathia • Cats with myeloproliferative disease

  10. Coagulation Tests Primary hemostasis • Platelet function tests • Academia • Must be performed within 2-3 hours of blood collection

  11. Coagulation Tests Primary hemostasis • Buccal mucosal Bleeding Time (BMBT) • Assesses primary hemostasis • Prolonged if platelets <20,000/ul • Rebleeding can indicate problems with secondary hemostasis • The only in clinic test that evaluates vessel and platelet function • Screen for vWDz in likely suspects • Reasonable pre-operative estimate of likelihood of surgical hemorrhage, if you check for rebleeding

  12. Coagulation Tests Primary hemostasis • How severe must Tpenia to cause spontaneous bleeding? • Can happen <50,000/ul • More often <20,000/ul • Splenomegaly of any kind can result in thrombocytopenia • Platelets sequestered in the spleen, liver or lymph nodes

  13. Coagulation Pathway

  14. Coagulation Pathway

  15. Coagulation Pathway

  16. Coagulation Tests Secondary hemostasis • Partial thromboplastin time (PTT) • Intrinsic and common pathways • Heparin acts on intrinsic pathway • Prothrombin time (PT) • Extrinsic and common pathways • PIVKA is a form of PT test • PIVKA is not specific for rodenticide toxicity • Factor 7 deficiency • Common pathway - DIC, liver failure • No clinical significance when PT/PTT are shorter than normal • PT <3 sec and PTT <5 sec prolonged may not be clinically significant

  17. Coagulation Tests Secondary hemostasis • Activated clotting time (ACT) • Less sensitive version of PTT • Intrinsic and common pathways • Platelets as well • Thrombocytopenia can elevate ACT by <10% • No such platelet effect on PTT • Factors must be 5% of normal for ACT to be elevated • If ACT is increased, things are really bad

  18. Coagulation Tests Secondary hemostasis • Thrombin time (TT) • Assesses fibrinogen activity • Part of common pathway

  19. Coagulation Tests Fibrinolysis • Fibrin degradation products (FDPs) • AKA FSPs – fibrin split products • Measure fibrinolysis • High with clot formation and breakdown over time • DIC • Chronic bleeding • Hypercoagulable state • Neoplasia • Cushings Disease • PLN, PLE • IMHA

  20. Coagulation Tests Fibrinolysis • D-dimers • Measure fibrinolysis • More specific for DIC than FDPs • Normal D-dimers exclude DIC as a diagnosis with 99.5% confidence level

  21. Anticoagulants • Antithrombin III • Produced by the liver • Activated by heparin • Modulates excessive coagulation • Consumed by coagulation • Lost with albumin – PLN, PLE • Protein C (vitamin K dependent) • Protein S (vitamin K dependent) • TFPI – Tissue Factor Pathway Inhibitor

  22. Coagulation Pathway –THAT’S Not ALL!!

  23. Fibrinolysis • tPA – tissue Plasminogen activator converts plasminogen within the clot to plasmin • Plasmin breaks down fibrin clot • So tPA promotes fibrinolysis, so that clots are only temporary • Urokinase and streptokinase work similarly • tPA, urokinase and streptokinase are the “clot busters”

  24. Excessive Fibrinolysis • Enzymes prevent excessive fibrinolysis which would lead to rebleeding • They break down the clot busters • Alpha2-antiplasmin • inactivates plasmin • PA1-I: tPA-inhibitor1 • Inactivates tPA and uPA • uPA – urokinase plasminogen activator • FDPs and d-Dimers inhibit the coagulation cascade by negative feedback

  25. Coags in Practice Why do them at all??? • Patient shows signs of coagulopathy • Excessive bleeding • thrombosis • Presurgical evaluation • Patient predisposed to coagulopathy • Procedure increases risk of bleeding • Rodenticide toxicity suspected • DIC suspected • Genetic screening for breeding • No expensive equipment for platelet count, ACT, BMBT • Can send out the rest

  26. Coags in Practice Platelet count Partial thromboplastin time (PTT) Prothrombin time (PT) • Reference lab • Human hospitals often not calibrated for animals (Pluto) • Synbiotics SCA 2000 • $2000-3000 • Idexx Coag Dx

  27. Coags in Practice Activated clotting time • Reference labs • Gray top tubes (other colors now) • Diatomaceous earth (DE) or kaolin • http://www.haemtech.com/ACT.htm • Warming block or hand heat • 2 ml whole blood in the tube immediately • Invert once every 15-30 seconds • First clot is the ACT • Normal less than 2 minutes • SCA 2000 • HESKA i-STAT

  28. Coags in Practice

  29. Coags in Practice

  30. Coags in Practice

  31. Coags in Practice Buccal Mucosal Bleeding Time (BMBT) • Simplate, Triplett, Surgicutt device • Lift the upper lip (gauze muzzle) • Remove the device safety tab • Place the device on the mucosa • Push the device trigger button • Dab dripping blood every 15 seconds, but don’t touch the clot

  32. Coags in Practice Buccal Mucosal Bleeding Time (BMBT) • When bleeding stops, you have BMBT • Normal is 2-4 minutes • 5 minutes isn’t worrisome • Check the patient in 10-15 minutes for rebleeding • DON’T DO BMBT IF: • Platelets <40,000/ul • Petechiae are present • ACT is increased

  33. Coags in Practice EVERY PRACTICE can have in house PLATELET COUNT, ACT & BMBT EVERY PRACTICE can use a lab for the rest

  34. Coags in Practice Tips for coag test sample handling • Take blood from a peripheral vein • Avoid cystocentesis if coagulopathy • Holding the vein off for too long can lead to platelet & fibrinolysis activation • Multiple sticks can lead to the same – you want a clean first stick. • If you don’t get blood quickly, move to another vein. • Hemolysis and severe lipemia can prevent accurate results

  35. Coags in Practice Tips for coag test sample handling • 1 citrate:9 blood • Vacuum tubes should autodraw • Run platelet count immediately • Run tests on whole citrated blood within 2 hours • Centrifuge promptly to harvest plasma for outside lab tests • Freeze immediately in plastic or siliconized glass tubes • Ship frozen on dry ice • May need special blue top clot tubes for FDPs – ask lab

  36. Coagulopathies - DDx Disorders of primary hemostasis • thrombocytopenia • thrombocytopathia • Von Willebrand Disease • vasculitis Disorders of secondary hemostasis • Congenital factor deficiencies • Liver disease (poor pdxn) • Vitamin K antagonism • Snake bite envenomation Disorders of both • Consumption – DIC, massive hemorrhage • Paraneoplastic coagulopathy

  37. Thrombocytopenia - DDx • Bone marrow disease – lack of production • Consumption • DIC • Massive hemorrhage • Destruction • immune mediated • Sequestration • Splenomegaly • Hepatomegaly • Lymphadenitis, lymphangitis • vasculitis

  38. Thrombocytopenia - DDx Infectious Diseases Multiple causes • Viruses • Canine – CDV, CHV, CPV, CAV2 • Feline – FeLV, FIV, panleukopenia, FIP • Arthropod-Borne • Ehrlichia spp. • Babesia spp. • Heamobartonella spp. • Arthropod-Borne • Rickettsia spp. • Leishmania spp. • Cytauxzoon spp. • Borrelia spp. • Bacterial • Sepsis • Borrelia spp. • Leptospira spp. • Fungal • Histoplasma spp. • Candida spp.

  39. Thrombocytopenia - DDx Neoplasia Multiple causes • Marrow suppression • Metastatic disease • Hematopoietic neoplasia • Lymphoma • Multiple myeloma • leukemias • DIC • Hemangiosarcoma • Inflammatory mammary carcinoma • Vasculitis • Cytotoxic drug therapy • Azathioprine • Chlorambucil • Cyclophosphamide • Doxorubicin

  40. Thrombocytopenia - DDx Drug Therapy Multiple causes • Impaired platelet pdxn • Immune destruction • Platelet dysfunction Antibiotics • Penicillin • Chloramphenicol • Sulfonamides Antifungals NSAIDs • Ibuprofen Cardiopulmonary drugs • Procainamide Cytotoxic drugs • Azathioprine • Chlorambucil • Cyclophosphamide • Doxorubicin Estrogen Methimazole

  41. Immune Mediated Thrombocytopenia • Primary – autoimmune • Very rare in cats • Dog breeds predisposed • Same as IMHA • Cocker spaniel • Poodle • Old English Sheepdog • Diagnosis of exclusion • Rule out other causes of Tpenia (normal coags, normal BMBT unless <5K platelets) • Rule out causes of secondary IMT • Platelets <50,000/ul • Increased megakaryocytes in the marrow • Response to immunosuppressive therapy

  42. Immune Mediated Thrombocytopenia • Secondary – same as for IMHA • infection • Drug therapy • Paraneoplastic • transfusion • Anti-platelet antibodies • Doesn’t distinguish between 1o & 2o IMT • Sensitive for IMT • But not very specific (many false negatives) • Low MPV – microthrombocytosis • MPV < 5.5 fL + platelets <20,000/ul is almost always IMT (primary or secondary) • But only 50% of dogs with IMT have this combination of abnormalities

  43. Breed Specific Thrombocytopenia • Greyhounds • Normal platelet count 150,00/ul • Coags normal • Remember greyhounds also predisposed to von Willebrand Disease and Babesia • Cavalier King Charles Spaniel • Normal coags • Normal platelets 25,000/ul-100,000/ul • Giant platelets on blood smear • CBC machines won’t count them • Platelet mass usually normal • Platelet mass = Platelet count x MPV • Causes no clinical problems

  44. Thrombocytopathia • Platelet dysfunction • hereditary • acquired • Acquired Thrombocytopathia • Drugs • Disease • Anemia • Liver failure (plus factor deficiency) • Uremia (plus vasculitis) • DIC (plus consumptive coagulopathy) • Paraproteinemia • Monoclonal gammopathy • Ehrlichia, plasma cell myeloma

  45. Thrombocytopathia - DDx Drug Therapy Antibiotics • Beta lactams • Carbenicillin • cephalosporins Antifungals NSAIDs • Aspirin • Phenylbutazone • Ibuprofen • Naproxen Cardiopulmonary drugs • Aminophylline • Verapamil • Diltiazem • Isoproterenol • Propranolol Dextran Phenothiazines CAUTION in pets with thrombocytopenia, undergoing surgery or signs of coagulopathy

  46. Thrombocytopathia • Hereditary Thrombocytopathia • Likely underdiagnosed • Otter hound, Great Pyrenees – thrombasthenia • Basset hound, Spitz • Persian cat – Chediak-Higashi • Cocker spaniel • Collie – cyclic neutropenia (stem cell defect) • Boxer • German shepherd • Consider BMBT prior to major surgery

  47. von Willebrand Disease Most common canine hereditary coagulopathy in dogs • Does not occur in cats • Clinical signs of primary hemostasis defect • Mucosal hemorrhage, prolonged bleeding after injury • Petechiae are rare • (Indy) • von Willebrand Factor is not a coagulation factor • Made by the endothelium • Acts as carrier protein for factor 8 • Severe vWDz can cause result in bleeding due to lack of secondary hemostasis

  48. von Willebrand Disease • Three subtypes of vWDz • Type 1 vWDz – most common – complex genetics • Mild to moderate bleeding • Low plasma vWAg, normal multimer distribution • Type 2 vWDz – simple recessive • Moderate to severe bleeding • Low vWAg, loss of high MW multimers • Type 3 vWDz – simple recessive • Severe bleeding • Total lack of vWF

  49. von Willebrand Disease • Diagnosis • Platelet count • Normal (may be mildly low if hypothyroid) • PT, PTT/ACT • Normal (increased of Type 3) • BMBT • Type 1: 5-12 minutes • Type 2&3: >12 minutes • vWFAg assay • carriers: 35-65% • Type 1: 5-30% (clinical <15%) • Type 2: 1-5%, no high MW multimers • Type 3: <0.1%

  50. von Willebrand Disease Type 1 - mild Airedale Akita Dachshund Doberman German shepherd Golden retriever Greyhound Irish wolfhound Manchester terrier Pembroke Corgi Poodle Schnauzer Sheltie Type 2 - moderate German shorthair pointer German wirehair pointer Type 3 - severe Chesapeake Bay Retriever Dutch kooiker Scottish terrier Sheltie Less commonly: Cocker spaniel Spitz Labrador retriever Pit bull terrier Rottweiler DNA Tests available for some breeds

More Related